DX-88 and HAE: a developmental perspective
- 1 December 2003
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 29 (3), 255-258
- https://doi.org/10.1016/s1473-0502(03)00170-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Molecular Genetics of C1 InhibitorImmunobiology, 1998
- Plasma bradykinin in angio-oedemaThe Lancet, 1998
- Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.The Journal of Immunology, 1997
- Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activitiesClinical and Experimental Immunology, 1994
- Hereditary and Acquired C1-Inhibitor DeficiencyMedicine, 1992
- Angioedema induced by a peptide derived from complement component C2.The Journal of Experimental Medicine, 1988
- C1 Inhibitor and Hereditary Angioneurotic EdemaAnnual Review of Immunology, 1988
- Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of “spontaneous” formation of bradykininJournal of Allergy and Clinical Immunology, 1983
- Prekallikrein Activation and High-Molecular-Weight Kininogen Consumption in Hereditary AngioedemaNew England Journal of Medicine, 1983
- Permeability-increasing activity in hereditary angioneurotic edema plasmaJournal of Clinical Investigation, 1969